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A
s a member of peroxiredoxin (Prx) 
family,  PrxIII  has  been  demon-
strated  to  play  an  important  role  in 
scavenging intracellular reactive oxygen 
species  (ROS).  Since  PrxIII  knockout 
mice exhibited oxidative stress in placen-
tas resembling pathophysiologic changes 
in placentas of human pre-eclampsia, we 
measured  blood  pressure  through  the 
carotid  artery  and  detected  oxidative 
status  by  western  blotting  in  pregnant 
mice.  We  did  not  notice  hypertension 
in  pregnant  PrxIII  knockout  mice  as 
compared  with  wild-type  littermates, 
although endothelin-1 was overexpressed 
in PrxIII-deficient placentas. Our results 
indicate  that  PrxIII  is  not  involved  in 
pre-eclamptic  development.  Instead, 
PrxIII is an indispensable antioxidant in 
placentas where oxidative stress exists.
Introduction
As a unique organ that connects mother 
and fetus, the placenta provides the place 
for materno-fetal exchange of gases, nutri-
ents  and  metabolic  products.  Since  pla-
centa is abundant in mitochondria, large 
amount of reactive oxygen species (ROS) 
is  continuously  produced  during  meta-
bolic processes. During pregnancy, ROS 
production is gradually elevated with the 
increase  of  energy  demand  due  to  both 
fetal and maternal requirements. Although 
small amount of ROS is considered to be 
a second messenger, excessive ROS would 
cause oxidative injuries on DNA, lipids, 
and proteins. Organisms have developed 
multiple antioxidant defenses against oxi-
dative  damage.  For  example,  placental 
antioxidant  activity  was  increased  with 
gestation  progression,1  and  higher  activ-
ity of superoxide dismutase was observed 
in  maternal  erythrocytes.2  More  impor-
tantly, mitochondrion possesses a primary 
antioxidant chain that is composed of per-
oxiredoxin III (PrxIII), thioredoxin II and 
thioredoxin reductase.3
As  a  member  of  peroxiredoxin  fam-
ily,  PrxIII  was  found  to  be  responsible 
to  oxidative  stress  in  placentas.4,5  We 
have  recently  observed  placental  oxida-
tive damage in PrxIII knockout (PrxIII-/-) 
mice.6  Interestingly,  our  findings  in 
PrxIII-deficient placentas were quite simi-
lar to the major pathophysiologic changes 
in  placentas  of  pre-eclampsia  (PE),7-9 
a  serious  pregnancy  complication  in 
human beings. Since it is speculated that 
increased placental lipid peroxides and/or 
tumor necrosis factor alpha (TNFalpha) 
cause activation of leukocytes which serve 
as  circulating  mediators  and  contribute 
to  endothelial  dysfunction  and  subse-
quent hypertension,10 we have investigated 
whether placental oxidative damage causes 
hypertensive disorders in mice resembling 
PE.
Results
Blood pressure in pregnant mice. Since 
oxidative damage in PrxIII-deficient pla-
centas  of  mice  resembled  pathological 
findings in pre-eclamptic placentas,6-9 we 
measured mean arterial blood pressure in 
pregnant mice trying to elucidate pathoge-
netic role of PrxIII in pre-eclamptic devel-
opment. As indicated in Table 1, there was 
no significant difference of blood pressure 
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through a tiny incision. Another end of 
the catheter was connected with a pressure 
transducer (Spectramed Medical Products, 
Singapore) whose output was fed into an 
amplifier (NEC-Sanei Co., Tokyo, Japan) 
and recorded. Age-matched non-pregnant 
female mice were used as controls.
Systemic detection of oxidative stress. 
Brains, hearts, lungs, livers, kidneys, skel-
etal muscles and placentas were removed 
from  maternal  mice  that  were  pregnant 
for  18  days.  Samples  from  age-matched 
non-pregnant mice were used as controls. 
The samples were homogenized through 
ultrasonic disruption and protein concen-
tration was detected by Bio-Rad protein 
assay kit. After separation on 15% SDS-
PAGE and transfer to Immobilon mem-
brane  (Millipore  Corporation),  proteins 
were  recognized  with  primary  antibody 
anti-ET-1  (Santa  cruz).  Visualization 
was achieved with ECL western blotting 
detection  system  (Amersham).  Anti-β-
actin antibody (Sigma) was used as inter-
nal control.
Statistic analysis. The value of blood 
pressure was presented as mean ± SEM and 
was  compared  among  PrxIII+/+, PrxIII+/- 
and PrxIII-/- mice by analysis of variance. 
p < 0.05 was considered to be statistically 
significant.
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one  of  the  main  causative  factors.13,14 
Malperfusion of the placenta was impli-
cated  as  a  cause  of  oxidative  stress  in 
complications of human pregnancy,15 and 
subsequent  endothelial  activation  and 
peripheral vascular contraction was con-
sidered  to  be  the  basic  pathophysiology 
of pre-eclampsia.16,17 Both TNFalpha and 
ET-1 were reported to play important roles 
in linking placental oxidative damage and 
systemic endothelial dysfunction in PE.17,18 
We detected high levels of TNFalpha and 
ET-1 in PrxIII-deficient placentas of mice, 
implying serious oxidative stress and poor 
perfusion  in  the  organs.  Nevertheless, 
we  did  not  notice  the  increase  of  ET-1 
in other organs except kidney and subse-
quent  hypertension  in  pregnant  PrxIII-/- 
mice.  Combining  with  our  results  and 
another report that PrxIII is significantly 
upregulated  in  pre-eclamptic  placentas,5 
we suppose that PrxIII is not involved in 
the pathogenesis of pre-eclamptic develop-
ment. Instead, it is very likely that PrxIII is 
an indispensable ROS scavenger in oxida-
tion-threatened placentas and contributes 
to the inhibition of PE progression.
Materials and Methods
Animals.  Experimental  mice  were  gen-
erated  by  mating  C57BL/6  mice  with 
PrxIII-/-  mice  to  generate  PrxIII+/-  off-
spring,  which  were  then  intercrossed  to 
produce PrxIII+/+, PrxIII+/- and PrxIII-/- lit-
termates for experiments. PrxIII genotypes 
were determined by PCR analysis as previ-
ously described.11 Use of the experimental 
animals was approved by the institutional 
ethics  committee  of  Tohoku  University, 
Japan.
Measurement of blood pressure. Mean 
arterial blood pressure of mice was mea-
sured through the carotid artery.12 After 
anesthesia with diethyl ether the carotid 
artery  of  maternal  mouse  was  isolated 
and a catheter was inserted into the artery 
before or after pregnancy among PrxIII+/+, 
PrxIII+/- and PrxIII-/- mice.
Systemic  oxidative  status  in  preg-
nant mice. To further understand oxida-
tive status in pregnant mice, we detected 
expression of endothelin-1 (ET-1) systemi-
cally.  As  shown  in Figure  1,  ET-1  pro-
tein was evidently enhanced in placentas 
derived  from  PrxIII-/-  mice,  which  was 
in accordance with our previous report.6 
Nevertheless, ET-1 expression was not sig-
nificantly elevated in other PrxIII-deficient 
organs  except  kidney  as  compared  with 
wild-type samples.
Discussion
We recently reported that PrxIII-deficiency 
resulted  in  excessive  lipid  peroxidation 
and  TNFalpha  production  in  placentas 
of mice,6 which was quite similar to the 
pathological  changes  in  pre-eclamptic 
placentas.7-9  We  then  measured  blood 
pressure in pregnant mice and found seri-
ous oxidative stress in placentas of PrxIII 
knockout  mice  without  subsequent  dys-
function  of  peripheral  endothelium  and 
hypertensive disorder.
PE is one of the most important preg-
nancy  complication  characterized  by 
hypertension,  proteinuria,  and  edema. 
Although the precise mechanism for pre-
eclamptic  occurrence  remains  unclear, 
oxidative  stress  was  considered  to  be 
Figure 1. western blotting analysis for Et-1 
expression in Prxiii+/+ (a) and Prxiii-/- (B) 
mouse organs including (from 1 to 7) brain, 
heart, lung, liver, kidney, placenta and skeletal 
muscle. Signals for ET-1 protein were signifi-
cantly enhanced in Prxiii knockout placenta 
and kidney as compared with wild-type 
organs.
Table 1. Blood pressure in Prxiii+/+, Prxiii+/- and Prxiii-/- mice before and after pregnancy
Blood Pressure  PrxIII+/+ PrxIII+/- PrxIII-/-
Before Pregnancy  95 ± 2 95 ± 2 95 ± 3
after Pregnancy 95 ± 6 93 ± 5 97 ± 5
Blood pressure in mice was measured as described in “Materials and methods” section (n = 10 for 
Prxiii+/+, Prxiii+/- and Prxiii-/- mice respectively). there was no significant difference of blood pres-
sure among individual groups before or after pregnancy (p > 0.05).www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  73
16.  Hung TH, Skepper JN, Burton GJ. In vitro ischemia-
reperfusion injury in term human placenta as a model 
for oxidative stress in pathological pregnancies. Am J 
Pathol 2001; 159:1031-43.
17.  Hung TH, Charnock-Jones DS, Skepper JN, Burton 
GJ.  Secretion  of  tumor  necrosis  factor-alpha  from 
human placental tissues induced by hypoxia-reoxy-
genation causes endothelial cell activation in vitro: a 
potential mediator of the inflammatory response in 
preeclampsia. Am J Pathol 2004; 164:1049-61.
18.  Fiore G, Florio P, Micheli L, Nencini C, Rossi M, 
Cerretani  D,  et  al.  Endothelin-1  triggers  placental 
oxidative stress pathways: putative role in preeclamp-
sia. J Clin Endocrinol Metab 2005; 90:4205-10.
12. Hori  K,  Saito  S.  Microvascular  mechanisms  by 
which  the  combretastatin  A-4  derivative  AC7700 
(AVE8062) induces tumour blood flow stasis. Br J 
Cancer 2003; 89:1334-44.
13.  Roberts JM, Lain KY. Recent insights into the patho-
genesis of pre-eclampsia. Placenta 2002; 23:359-72.
14.  Hoffmann DS, Weydert CJ, Lazartigues E, Kutschke 
WJ, Kienzle MF, Leach JE, et al. Chronic tempol 
prevents  hypertension,  proteinuria  and  poor  feto-
placental outcomes in BPH/5 mouse model of preec-
lampsia. Hypertension 2008; 51:1058-65.
15.  Hung TH, Skepper JN, Charnock-Jones DS, Burton 
GJ.  Hypoxia-reoxygenation:  a  potent  inducer  of 
apoptotic changes in the human placenta and possible 
etiological  factor  in  preeclampsia.  Circ  Res  2002; 
90:1274-81.
8.  Morikawa  S,  Kurauchi  O,  Tanaka  M,  Yoneda  M, 
Uchida K, Itakura A, et al. Increased mitochondrial 
damage by lipid peroxidation in trophoblast cells of 
preeclamptic placentas. Biochem Mol Biol Int 1997; 
41:767-75.
9.  Shibata E, Ejima K, Nanri H, Toki N, Koyama C, 
Ikeda M, et al. Enhanced protein levels of protein 
thiol/disulphide  oxidoreductases  in  placentae  from 
pre-eclamptic subjects. Placenta 2001; 22:566-72.
10.  Gupta S, Agarwal A, Sharma RK. The role of placen-
tal oxidative stress and lipid peroxidation in preec-
lampsia. Obstet Gynecol Surv 2005; 60:807-16.
11.  Li  L,  Shoji  W,  Takano  H,  Nishimura  N,  Aoki  Y, 
Takahashi R, et al. Increased susceptibility of MER5 
(peroxiredoxin III) knockout mice to lipopolysaccha-
ride (LPS)-induced oxidative stress. Biochem Biophys 
Res Commun 2007; 355:715-21.